Biogen Inc (BIIB) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Biogen Inc   (NASDAQ: BIIB)

Biogen Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIIB Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 73.32 % 69.56 % 54.17 % 38.76 %
Gross Margin (Q1 TTM) 75.49 % 72.25 % 55.57 % 38.04 %
Gross Profit Margin 5 Yr. Avg. 76.89 % 68.86 % 53.76 % 33.44 %
EBITDA Margin (Q1 MRQ) 23.49 % 20.62 % 19.62 % 20.72 %
EBITDA Margin (Q1 TTM) 24.39 % 27.23 % 21.02 % 19.28 %
EBITDA Margin 5 Yr. Avg. 26.13 % 23.3 % 31.89 % 22.83 %
Operating Margin (Q1 MRQ) 16.87 % 11.28 % 16.57 % 16.03 %
Operating Margin (Q1 TTM) 22.48 % 16.53 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. 25.38 % 6.03 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q1 MRQ) 15.24 % 7.4 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q1 TTM) 16.33 % 15.08 % 12.85 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 19.96 % 9.88 % 10.45 % 12.49 %
Net Margin (Q1 MRQ) 12.89 % 2.64 % 8.14 % 11.41 %
Net Margin (Q1 TTM) 13.81 % 11.09 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. 17.32 % 6.58 % 6.23 % 9.95 %



Business Segment Profit Margin
 
MS Product
  Explore MS Product Segment  -
MS Product Revenues U S
  Explore MS Product Revenues U S Segment  -
MS Product Revenues Rest of World
  Explore MS Product Revenues Rest of World Segment  -
Fumarate
  Explore Fumarate Segment  -
Fumarate U S
  Explore Fumarate U S Segment  -
Fumarate Rest of World
  Explore Fumarate Rest of World Segment  -
TECFIDERA
  Explore TECFIDERA Segment  -
TECFIDERA U S
  Explore TECFIDERA U S Segment  -
TECFIDERA Rest of World
  Explore TECFIDERA Rest of World Segment  -
VUMERITY
  Explore VUMERITY Segment  -
VUMERITY U S
  Explore VUMERITY U S Segment  -
VUMERITY Rest of World
  Explore VUMERITY Rest of World Segment  -
Interferon
  Explore Interferon Segment  -
Interferon U S
  Explore Interferon U S Segment  -
Interferon Rest of World
  Explore Interferon Rest of World Segment  -
AVONEX
  Explore AVONEX Segment  -
AVONEX U S
  Explore AVONEX U S Segment  -
AVONEX Rest of World
  Explore AVONEX Rest of World Segment  -
PLEGRIDY
  Explore PLEGRIDY Segment  -
PLEGRIDY U S
  Explore PLEGRIDY U S Segment  -
PLEGRIDY Rest of World
  Explore PLEGRIDY Rest of World Segment  -
TYSABRI
  Explore TYSABRI Segment  -
TYSABRI U S
  Explore TYSABRI U S Segment  -
TYSABRI Rest of World
  Explore TYSABRI Rest of World Segment  -
Rare Disease Product Revenue
  Explore Rare Disease Product Revenue Segment  -
Rare Disease Product Revenue U S
  Explore Rare Disease Product Revenue U S Segment  -
Rare Disease Product Revenue Rest of World
  Explore Rare Disease Product Revenue Rest of World Segment  -
QALSODY
  Explore QALSODY Segment  -
QALSODY U S
  Explore QALSODY U S Segment  -
QALSODY Rest of World
  Explore QALSODY Rest of World Segment  -
SPINRAZA
  Explore SPINRAZA Segment  -
SPINRAZA U S
  Explore SPINRAZA U S Segment  -
SPINRAZA Rest of World
  Explore SPINRAZA Rest of World Segment  -
Biosimilars
  Explore Biosimilars Segment  -
Biosimilars Rest of World
  Explore Biosimilars Rest of World Segment  -
BENEPALI
  Explore BENEPALI Segment  -
BENEPALI Rest of World
  Explore BENEPALI Rest of World Segment  -
IMRALDI
  Explore IMRALDI Segment  -
IMRALDI Rest of World
  Explore IMRALDI Rest of World Segment  -
FLIXABI
  Explore FLIXABI Segment  -
FLIXABI Rest of World
  Explore FLIXABI Rest of World Segment  -
Other
  Explore Other Segment  -
Other U S
  Explore Other U S Segment  -
Other Rest of World
  Explore Other Rest of World Segment  -
ZURZUVAE
  Explore ZURZUVAE Segment  -
ZURZUVAE U S
  Explore ZURZUVAE U S Segment  -
Contract manufacturing revenue
  Explore Contract manufacturing revenue Segment  -
Royalty and other revenue
  Explore Royalty and other revenue Segment  -
Contract manufacturing royalty and other revenue
  Explore Contract manufacturing royalty and other revenue Segment  -
Genentech
  Explore Genentech Segment  -
Revenue from anti-CD20 therapeutic programs
  Explore Revenue from anti-CD20 therapeutic programs Segment  -
Royalty Attributed To OCREVUS
  Explore Royalty Attributed To OCREVUS Segment  -
Product revenue net
  Explore Product revenue net Segment  -
Product revenue net U S
  Explore Product revenue net U S Segment  -
Product revenue net Rest of World
  Explore Product revenue net Rest of World Segment  -
SKYCLARYS
  Explore SKYCLARYS Segment  -
SKYCLARYS U S
  Explore SKYCLARYS U S Segment  -
SKYCLARYS Rest of World
  Explore SKYCLARYS Rest of World Segment  -
Distributor One
  Explore Distributor One Segment  -
Distributor Two
  Explore Distributor Two Segment  -
Alzheimer s collaboration revenue
  Explore Alzheimer s collaboration revenue Segment  -
Alzheimer s Collaboration
  Explore Alzheimer s Collaboration Segment  -
Reportable Segment
  Explore Reportable Segment Segment  -
ZURZUVAE Rest of World
  Explore ZURZUVAE Rest of World Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 23.98 % 1.35 % 0.21 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 24.16 % 17.88 % 14.06 % 9.26 %
Free Cash Flow Margin 5 Yr. Avg. - 17.1 % 15.38 % 14.46 %
Net Cash Flow Margin (Q1 MRQ) 15.83 % 0.42 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) 7.39 % 4.99 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 10.9 % 3.13 % 5.85 %
Effective Tax Rate (Q1 MRQ) 15.41 % 63.94 % 25.41 % 18.85 %
Effective Tax Rate (Q1 TTM) 15.47 % 26.53 % 22.84 % 19.36 %
Effective Tax Rate 5 Yr. Avg. 12.47 % -399.76 % 20.39 % 19.86 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.